Why is selank not FDA approved?
This site's US legal field is not approved, research use only. Selank is approved in Russia for easing anxiety. UK: not licensed. Australia: not approved. Canada: not approved. The record in people on this site is one Russian study of 62 patients with anxiety disorder or nervous exhaustion (neurasthenia), who got either Selank or medazepam, an older anti-anxiety drug. Both eased anxiety about equally, and there was no dummy-pill group. That is not the kind of large, independent study program that FDA approval of a new US drug usually rests on. Being unapproved in the US does not mean Russia did not license it.
Every FDA-approved compound in the archive, as a list
Studies in people from the compound pages this answer belongs to
- Selank
- Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia 2008 PMID 18454096
- [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]. 2014 PMID 25176261
- [Optimization of the treatment of anxiety disorders with selank]. 2015 PMID 26356395
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of further names and published absences. Leftover harvested questions after the first two absence sets: more brand versus molecule names, side effects the citations did not count, compounding formulas this catalogue does not hold, national FDA and Australia fields, trial windows rather than an onset clock, named combinations with no interaction table, and oral routes that have not been studied.